Decreased gray matter volume is associated with the subtypes of psychotic symptoms in patients with antipsychotic-naive mild or moderate Alzheimer's disease

被引：0
|
作者：
Chung, Y. I. [1 ,2 ]
Lee, Y. [3 ,4 ]
Park, J. [3 ,4 ]
Lee, B. [3 ,4 ]
Moon, E. [3 ,4 ]
Kim, J. [1 ,5 ]
Kim, H. [3 ,6 ]
Mun, C. [7 ]
机构：
[1] Pusan Natl Univ, Med Sch, Yangsan Si, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Yangsan Si, South Korea
[3] Pusan Natl Univ, Med Sch, Busan, South Korea
[4] Pusan Natl Univ Hosp, Psychiat, Busan, South Korea
[5] Pusan Natl Univ, Yangsan Hosp, Psychiat, Yangsan Si, South Korea
[6] Pusan Natl Univ Hosp, Radiol, Busan, South Korea
[7] Inje Univ, Biomed Engn, Gimhae, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
D O I：
10.1016/S0924-977X(16)31737-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.5.b.001
引用
收藏
页码：S639 / S640
页数：2
相关论文
共 50 条
  • [21] Glutamate Levels in the Associative Striatum of Antipsychotic-Naive First Episode Psychotic Patients and Subjects with Prodromal Symptoms of Schizophrenia
    de la Fuente-Sandoval, Camilo
    Leon-Ortiz, Pablo
    Stephano, Sylvana
    Favila, Rafael
    Graff-Guerrero, Ariel
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 250S - 251S
  • [22] Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's Disease
    Rozzini, Luca
    Chilovi, Barbara Vicini
    Bertoletti, Erik
    Trabucchi, Marco
    Padovani, Alessandro
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 19 (03) : 220 - 223
  • [23] Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's Disease
    Rozzini L.
    Chilovi B.V.
    Bertoletti E.
    Trabucchi M.
    Padovani A.
    Aging Clinical and Experimental Research, 2007, 19 (3) : 220 - 223
  • [24] Apolipoprotein E and Gray Matter Volume Loss in Patients with Mild Cognitive Impairment and Alzheimer Disease
    Spampinato, Maria Vittoria
    Rumboldt, Zoran
    Hosker, Robert J.
    Mintzer, Jacobo E.
    RADIOLOGY, 2011, 258 (03) : 843 - 852
  • [25] Factors associated with psychotic symptoms in Alzheimer's disease
    Hirono, N
    Mori, E
    Yasuda, M
    Ikejiri, Y
    Imamura, T
    Shimomura, T
    Ikeda, M
    Hashimoto, M
    Yamashita, H
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (05): : 648 - 652
  • [26] Gray matter atrophy in mild cognitive impairment and mild Alzheimer's disease
    Apostolova, LG
    Steiner, CA
    Akopyan, GG
    Toga, AW
    Cuminings, JL
    Thompson, PM
    NEUROLOGY, 2006, 66 (05) : A117 - A117
  • [27] ASSOCIATION OF VITAMIN-D WITH HIPPOCAMPAL GRAY MATTER VOLUME IN ANTIPSYCHOTIC - NAIVE SCHIZOPHRENIA PATIENTS
    Shivakumar, Venkataram
    Kalmady, Sunil V.
    Anekal, Amaresha C.
    Narayanaswamy, Janardhanan C.
    Jose, Dania
    Joseph, Boban
    Venkatasubramanian, Ganesan
    Ravi, Vasanthapuram
    Gangadhar, Bangalore N.
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S366 - S366
  • [28] Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease
    Novak, Gerald
    Fox, Nick
    Clegg, Shona
    Nielsen, Casper
    Einstein, Steven
    Lu, Yuan
    Tudor, Iulia Cristina
    Gregg, Keith
    Di, Jianing
    Collins, Peter
    Wyman, Bradley T.
    Yuen, Eric
    Grundman, Michael
    Brashear, H. Robert
    Liu, Enchi
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 49 (04) : 1123 - 1134
  • [29] Independent Effects of Age and Alzheimer's Disease on Gray Matter Volume
    Raji, Cyrus
    Lopez, Oscar
    Kuller, Lewis
    Carmichael, Owen
    Becker, James
    NEUROLOGY, 2009, 72 (11) : A171 - A171
  • [30] Mapping gray matter volume and cortical thickness in Alzheimer's disease
    Guo, Xiaojuan
    Li, Ziyi
    Chen, Kewei
    Yao, Li
    Wang, Zhiqun
    Li, Kuncheng
    MEDICAL IMAGING 2010: BIOMEDICAL APPLICATIONS IN MOLECULAR, STRUCTURAL, AND FUNCTIONAL IMAGING, 2010, 7626
12345